The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 23, 2025

Filed:

Sep. 03, 2021
Applicant:

Shandong Simcere Biopharmaceutical Co., Ltd., Shandong, CN;

Inventors:

Yingying Hu, Shanghai, CN;

Zhuoxiao Cao, Shanghai, CN;

Renhong Tang, Jiangsu, CN;

Hu Ge, Shanghai, CN;

Yayuan Fu, Shanghai, CN;

Jinsheng Ren, Jiangsu, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/55 (2006.01); A61P 37/02 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
C07K 14/55 (2013.01); A61P 37/02 (2018.01); C12N 15/63 (2013.01); C07K 2319/31 (2013.01);
Abstract

The present disclosure discloses IL-2 mutants and uses thereof. More specifically, the disclosure provides IL-2 mutants and corresponding fusion proteins, conjugates, nucleic acid fragments, vectors, host cells, methods for preparing the mutants or fusion proteins, IL-2 mutants or fusion proteins prepared according to the methods, pharmaceutical compositions, pharmaceutical uses, methods for treating diseases, and methods for preferentially stimulating regulatory T cells. Compared to wild-type IL-2, the IL-2 mutants of the present disclosure have higher Tm values and improved stability; alternatively, the IL-2 mutants of the present disclosure have an increased yield or changed binding activity to the IL-2Rβγ complexes compared to wild-type IL-2.


Find Patent Forward Citations

Loading…